Lupus carries high risk of all-cause mortality in the young
Study also shows a survival benefit of low-dose hydroxychloroquine
Adults younger than 40 with systemic lupus erythematosus (SLE) have nearly five times the risk of mortality compared with peers who don’t have the condition, a study shows.
The finding comes from a linked analysis of records in a UK primary care database in which mortality was compared for the 4340 people with SLE and nearly 22,000 age and sex-matched controls.
